SRx Health Solutions Inc. (SRXH)
NYSEAMERICAN: SRXH · Real-Time Price · USD
0.1417
-0.0068 (-4.58%)
Feb 17, 2026, 11:20 AM EST - Market open

SRx Health Solutions Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22
9.346.53-119.4293.18
Revenue Growth (YoY)
---28.16%-
Cost of Revenue
6.765.01-95.7279.8
Gross Profit
2.581.53-23.7113.39
Selling, General & Admin
14.489.63-30.8113.22
Operating Expenses
14.489.63-32.5514.56
Operating Income
-11.9-8.11--8.85-1.17
Interest Expense
-1.92-0.63--1.83-0.76
Earnings From Equity Investments
-----0.18
Other Non Operating Income (Expenses)
-0.47---0.130.09
EBT Excluding Unusual Items
-14.28-8.73--10.81-2.02
Merger & Restructuring Charges
-3.3-3.3--0.18-
Other Unusual Items
0.333.4---
Pretax Income
-17.25-8.64--10.99-2.02
Income Tax Expense
0--0.20.44
Earnings From Continuing Operations
-17.25-8.64--11.18-2.46
Earnings From Discontinued Operations
-32.38-36.37-43.05--
Net Income
-49.64-45.01-43.05-11.18-2.46
Net Income to Common
-49.64-45.01-43.05-11.18-2.46
Shares Outstanding (Basic)
242122121
Shares Outstanding (Diluted)
242122121
Shares Change (YoY)
7.10%-4.40%78.22%1659.27%-
EPS (Basic)
-2.10-2.13-1.95-0.90-3.50
EPS (Diluted)
-2.10-2.13-1.95-0.90-3.50
Free Cash Flow
--16.67-1.481.583.15
Free Cash Flow Per Share
--0.79-0.070.134.48
Gross Margin
27.62%23.36%-19.85%14.36%
Operating Margin
-127.35%-124.06%--7.41%-1.26%
Profit Margin
-531.39%-688.80%--9.36%-2.64%
Free Cash Flow Margin
--255.07%-1.32%3.38%
EBITDA
-12.95-8.08--7.07-0.54
EBITDA Margin
-138.68%-123.58%--5.92%-0.58%
D&A For EBITDA
-1.060.034.391.770.63
EBIT
-11.9-8.11--8.85-1.17
EBIT Margin
-127.35%-124.06%--7.41%-1.26%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q